Ilynn Bulatao

856 total citations
18 papers, 582 citations indexed

About

Ilynn Bulatao is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, Ilynn Bulatao has authored 18 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Hepatology and 5 papers in Transplantation. Recurrent topics in Ilynn Bulatao's work include Liver Disease and Transplantation (10 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Ilynn Bulatao is often cited by papers focused on Liver Disease and Transplantation (10 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Ilynn Bulatao collaborates with scholars based in United States. Ilynn Bulatao's co-authors include C. Burcin Taner, Darrin L. Willingham, Justin H. Nguyen, David J. Kramer, Dana K. Perry, Lena Sibulesky, Andrew P. Keaveny, Jennifer S. Albrecht, Steven M. Scharf and Sarah E. Tom and has published in prestigious journals such as Blood, SLEEP and Transplantation.

In The Last Decade

Ilynn Bulatao

16 papers receiving 575 citations

Peers

Countries citing papers authored by Ilynn Bulatao

Since Specialization

Citations

This map shows the geographic impact of Ilynn Bulatao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilynn Bulatao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilynn Bulatao more than expected).

Fields of papers citing papers by Ilynn Bulatao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilynn Bulatao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilynn Bulatao. The network helps show where Ilynn Bulatao may publish in the future.

Co-authorship network of co-authors of Ilynn Bulatao

This figure shows the co-authorship network connecting the top 25 collaborators of Ilynn Bulatao. A scholar is included among the top collaborators of Ilynn Bulatao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilynn Bulatao. Ilynn Bulatao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis 2025 ·Annals of Noninvasive Electrocardiology ·Asma Dilawari, Marie Krantz, Ilynn Bulatao, Hee‐Koung Joeng, Matthew Neilson, Suparna Wedam, Xin Gao, Mallorie H. Fiero, Abhilasha Nair, Marc R. Theoret, Laleh Amiri‐Kordestani	0
2	Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses 2024 ·Blood ·Nina Kim, (unknown), Ilynn Bulatao, Jonathon Vallejo, Yuan Li Shen, Dianne Pulte, Marc R. Theoret, R. Angelo de Claro, Kelly J. Norsworthy	0
3	Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration 2022 ·Drug Safety ·David Croteau, Ellen Pinnow, Eileen Wu, Mónica Muñoz, Ilynn Bulatao, Gerald J. Dal Pan	17
4	The Impact of Variability in Patient Exposure During Premarket Clinical Development on Postmarket Safety Outcomes 2021 ·Clinical Pharmacology & Therapeutics ·(unknown), Ellen Pinnow, Ilynn Bulatao, (unknown), (unknown), (unknown), Gerald J. Dal Pan	5
5	Postmarketing Safety‐Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002–2014: Similarities and Differences With New Molecular Entities 2020 ·Clinical Pharmacology & Therapeutics ·Ilynn Bulatao, Ellen Pinnow, (unknown), (unknown), (unknown), (unknown), Gerald J. Dal Pan	15
6	Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries 2019 ·SLEEP ·Emerson M. Wickwire, Sarah E. Tom, Steven M. Scharf, (unknown), Ilynn Bulatao, Jennifer S. Albrecht	105
7	Functional status predicts major complications and death after endovascular repair of abdominal aortic aneurysms 2017 ·Journal of Vascular Surgery ·Donald G. Harris, Ilynn Bulatao, Connor P. Oates, (unknown), Charles B. Drucker, (unknown), Tanya R. Flohr, Robert S. Crawford	35
8	PC054. Functional Status Predicts Major Complications and Death After Endovascular Repair of Abdominal Aortic Aneurysms 2016 ·Journal of Vascular Surgery ·Donald G. Harris, Connor P. Oates, Ilynn Bulatao, Charles B. Drucker, (unknown), Shahab Toursavadkohi, Rajabrata Sarkar, Robert S. Crawford	1
9	Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes 2015 ·American Journal of Roentgenology ·(unknown), Ilynn Bulatao, Andrew P. Keaveny, Justin H. Nguyen, Ricardo Paz‐Fumagalli, C. Burcin Taner	18
10	Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: Single-center and organ procurement and transplantation network analyses 2014 ·Liver Transplantation ·Hani M. Wadei, Ilynn Bulatao, Thomas A. Gonwa, L. Martin, (unknown), Andrew P. Keaveny, Barry G. Rosser, C. Burcin Taner	26
11	Avoiding Stay in the Intensive Care Unit After Liver Transplantation: A Score to Assign Location of Care 2014 ·American Journal of Transplantation ·Ilynn Bulatao, Michael G. Heckman, Bhupendra Rawal, Stephen Aniskevich, Timothy Shine, Andrew P. Keaveny, D.K. Perry, Juan Canabal, Darrin L. Willingham, C. Burcin Taner	33
12	Proteinuria Following Sirolimus Conversion is Associated With Deterioration of Kidney Function in Liver Transplant Recipients 2012 ·Transplantation ·Hani M. Wadei, (unknown), Andrew P. Keaveny, Barry Rosser, Melanie Jones, L. Martin, Ilynn Bulatao, Thomas A. Gonwa	15
13	Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors 2012 ·Transplant International ·C. Burcin Taner, Ilynn Bulatao, Dana K. Perry, Lena Sibulesky, Darrin L. Willingham, David J. Kramer, Justin H. Nguyen	89
14	Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts 2012 ·Annals of Hepatology ·C. Burcin Taner, Ilynn Bulatao, (unknown), Dana K. Perry, Darrin L. Willingham, Lena Sibulesky, Barry G. Rosser, Juan Canabal, Justin H. Nguyen, David J. Kramer	10
15	Should donation after cardiac death liver grafts be used for retransplantation? 2011 ·Annals of Hepatology ·Dana K. Perry, Darrin L. Willingham, Lena Sibulesky, Ilynn Bulatao, Justin H. Nguyen, C. Burcin Taner	10
16	Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus 2011 ·Liver Transplantation ·C. Burcin Taner, Ilynn Bulatao, Andrew P. Keaveny, Darrin L. Willingham, Surakit Pungpapong, Dana K. Perry, Barry G. Rosser, Denise M. Harnois, (unknown), Justin H. Nguyen	31
17	Is a Mandatory Intensive Care Unit Stay Needed After Liver Transplantation? Feasibility of Fast-Tracking to the Surgical Ward After Liver Transplantation 2011 ·Liver Transplantation ·C. Burcin Taner, Darrin L. Willingham, Ilynn Bulatao, Timothy Shine, (unknown), Klaus D. Torp, Juan Canabal, Justin H. Nguyen, David J. Kramer	58
18	Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation After Cardiac Death Donors 2011 ·Liver Transplantation ·C. Burcin Taner, Ilynn Bulatao, Darrin L. Willingham, Dana K. Perry, Lena Sibulesky, Surakit Pungpapong, Jaime Aranda‐Michel, Andrew P. Keaveny, David J. Kramer, Justin H. Nguyen	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact